As part of an ongoing mission to fund life changing research, Lung Foundation Australia is today awarding 13 research grants from the Hope Research Fund.
At today’s Hope Research Fund lunch, 13 exceptional researchers from around the country will be awarded $876k in grants, in several different research areas, including asthma, bronchiectasis, Chronic Obstructive Pulmonary Disease (COPD), Interstitial Lung Disease (ILD), and lung cancer.
One such researcher is Dr Arwel Jones of Monash University, who is awarded the $120,000 Lung Foundation Australia – Boehringer Ingelheim Fellowship in COPD grant.
Dr Jones is an emerging global leader in exercise and COPD, holding a unique combination of expertise in immunology and applied health which he aims to use in this research project to answer an unmet clinical need in COPD.
The project, titled EXERT (Exercise for Exacerbations and Rhinovirus Treatment), aims to test the effect of exercise on inflammatory and anti-viral responses during COPD exacerbation.
Exacerbations in people with COPD are responsible for more than 70,000 hospitalisations in Australia each year, and this research is key in improving quality of life for those living with this incurable lung disease.
The Hope Research Fund aims to not only invest in discovering scientific breakthroughs but bring new hope to millions of Australians impacted by lung disease and lung cancer.
Lung Foundation Australia Launched the Hope Research Fund last year with the vision of creating Australia’s leading national long-term commitment to fund life-changing lung disease and cancer research, which is severely underfunded.
With a goal of raising $50 million by 2030, the Hope Research Fund relies heavily on the generosity of Gifts in Wills to fund this life changing research.
Give the gift of hope through research
Make a real difference to the millions of Australians impacted by a lung condition, like Ethan, and provide hope, by donating or leaving a legacy gift, no matter how big or small.